← Open Payments lookup

WADE HACHINSKY: Open Payments

NPI 1598744419 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,521 in 90 payments from 14 companies in 2025. Trend: 2023 $1,367 · 2024 $1,635 · 2025 $1,521

Food & beverage: $1,521
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$319
ABBVIE INC.17$204
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$202
Vanda Pharmaceuticals Inc.8$167
E.R. Squibb & Sons, L.L.C.6$119
Neurocrine BioSciences, Inc.5$106
Lundbeck LLC4$87
Axsome Therapeutics, Inc.5$87
Collegium Pharmaceutical, Inc.4$73
Takeda Pharmaceuticals U.S.A., Inc.3$60

Products named: REXULTI, VRAYLAR, CAPLYTA, HETLIOZ, ABILIFY ASIMTUFII, COBENFY, INGREZZA, Jornay PM.

Industry payments across KS — which companies pay providers there.